Atripla Prices, Coupons and Patient Assistance Programs
Atripla (efavirenz/emtricitabine/tenofovir) is a member of the antiviral combinations drug class and is commonly used for HIV Infection, Nonoccupational Exposure and Occupational Exposure.
Atripla Prices
This Atripla price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies. The cost for Atripla oral tablet (600 mg-200 mg-300 mg) is around $2,852 for a supply of 30 tablets, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
Atripla is available as a brand name drug only, a generic version is not yet available. For more information, read about generic Atripla availability.
Oral Tablet
| Quantity | Per unit | Price |
|---|---|---|
| 30 | $95.07 | $2,851.99 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
Print NowThe free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Atripla Coupons and Rebates
Atripla offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.
Atripla BMS3assist Co-pay program: Eligible patients may save up to $7500 per year with no monthly limit; contact your healthcare provider or the program at 888-281-8981.
| Applies to: | Atripla |
| Number of uses: | Per prescription until program expires |
| Expires | December 31, 2018 |
Patient Assistance Programs for Atripla
Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.
Provider: Advancing Access Program
Elligibility requirements:
- Must be uninsured
- Based on FPL
- Medically appropriate condition/diagnosis
- Must be a US resident
- Insurance benefits, claims assistance and/or other reimbursement help is offered. If the application is for Vistide, then prescription must be included because it will be sent to the doctor's office. The other medications are given using a pharmacy card. This program is for outpatient use only. This Program participates in the CPAPA. This single common application allows uninsured HIV-positive individuals with low incomes to use one application to apply for multiple assistance programs. IMPORTANT: Send completed CPAPA to the corresponding addresses listed for each company.
Applicable drugs:
- Atripla (efavirenz-emtricitabine-tenofovir disoproxil fumarate)
Provider: Patient Access Network Foundation (PAN)
Elligibility requirements:
- *See Additional Information section below
- Between 400-500% of FPL
- Medically appropriate condition/diagnosis
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
- Atripla (efavirenz-emtricitabine-tenofovir disoproxil fumarate)
More about Atripla (efavirenz / emtricitabine / tenofovir)
- Atripla Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 99 Reviews
- Drug class: antiviral combinations
